Orally Administered SYN-020 Observed to be Well Tolerated in Healthy Volunteers; A Second Phase 1 Multiple-Ascending Dose Study is on Track to Begin in Q3 2021 ROCKVILLE, Md., June 29, 2021 ...
Total alkaline phosphatase (ALP) levels increased progressively across chronic kidney disease (CKD) stages, driven by an increase in liver, bone, and intestinal fractions. Liver ALP was linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results